Drug Maker United Therapeutics

MD 2017 Independent Pharmacies

DOJ False Claims Act Anti Kickback

Penalty

$210 million

Outcome

Drug Maker United Therapeutics Agrees to Pay $210 Million to Resolve False Claims Act Liability for Paying Kickbacks

Details

Drug Maker United Therapeutics — DOJ Enforcement (2017)

DOJ took enforcement action against Drug Maker United Therapeutics in MD in 2017 involving false claims act, anti kickback violations in the Independent Pharmacies sector.

Penalty: $210 million

Violation types: False Claims Act, Anti Kickback
Entity type: Pharmacy
Penalty type: Settlement
Location: MD

Source: DOJ Press Release — Drug Maker United Therapeutics Agrees to Pay $210 Million to Resolve False Claims Act Liability for Paying Kickbacks

How Crucible Prevents This

Crucible's billing compliance controls enforce documentation-to-claims reconciliation and flag billing anomalies before false claims are submitted. Crucible monitors referral patterns and financial arrangements to flag potential anti-kickback violations.

Source: DOJ Press Release — Drug Maker United Therapeutics Agrees to Pay $210 Million to Resolve False Claims Act Liability for Paying Kickbacks

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works